Medicare Enrolled

Dr. Veita Bland, M.D.

Family Medicine · Greensboro, NC
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Consulting-driven
1317 N ELM ST, Greensboro, NC 27401
3363731557
In practice since 2006 (20 years)
NPI: 1083675433 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bland from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bland? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bland

Dr. Veita Bland is a family medicine specialist in Greensboro, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Bland performed 541 Medicare services across 268 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bland received a total of $50,902 from 59 pharmaceutical and/or device companies across 792 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bland is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 50% volume in NC $50,902 industry payments

Medicare Practice Summary

Medicare Utilization ↗
541
Medicare services
Top 50% in NC for family medicine
268
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~27 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
303 $71 $260
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
52 $61 $175
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
43 $119 $272
Chronic care management, additional 20 min/month
This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month.
38 $34 $73
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
36 $3 $14
Chronic care management, first 20 min/month
This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions.
36 $41 $88
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
33 $3 $20
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$50,902
Total received (2018-2024)
Avg $7,272/year across 7 years
Top 1% in NC for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
792
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$37,744 (74.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,072 (25.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$85 (0.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$9,005
2023
$2,734
2022
$17,201
2021
$5,615
2020
$11,548
2019
$2,526
2018
$2,271

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$8,400
Mylan Specialty L.P.
$84
Lilly USA, LLC
$77
Novo Nordisk Inc
$58
Merck Sharp & Dohme LLC
$47
PFIZER INC.
$43
Corcept Therapeutics
$34
AstraZeneca Pharmaceuticals LP
$33
Astellas Pharma US Inc
$33
SHIELD THERAPEUTICS INC
$31
Sumitomo Pharma America, Inc.
$28
Otsuka America Pharmaceutical, Inc.
$24
Actelion Pharmaceuticals US, Inc.
$23
Amgen Inc.
$21
Novartis Pharmaceuticals Corporation
$19
Bayer Healthcare Pharmaceuticals Inc.
$17
GlaxoSmithKline, LLC.
$17
Medtronic, Inc.
$16
Top 3 companies account for 95.1% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Scientific Affairs, LLC
$34,022
Amgen Inc.
$2,012
AstraZeneca Pharmaceuticals LP
$1,816
Otsuka Pharmaceutical Development & Commercialization, Inc.
$1,600
Novo Nordisk Inc
$1,538
Bayer HealthCare Pharmaceuticals Inc.
$1,224
Lilly USA, LLC
$784
SANOFI-AVENTIS U.S. LLC
$747
Boehringer Ingelheim Pharmaceuticals, Inc.
$716
GlaxoSmithKline, LLC.
$572
Novartis Pharmaceuticals Corporation
$464
Astellas Pharma US Inc
$410
Merck Sharp & Dohme Corporation
$394
Sunovion Pharmaceuticals Inc.
$386
Takeda Pharmaceuticals U.S.A., Inc.
$340
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$322
AbbVie Inc.
$275
Amarin Pharma Inc.
$239
PFIZER INC.
$233
Corcept Therapeutics
$230
Esperion Therapeutics, Inc.
$210
Janssen Pharmaceuticals, Inc
$189
ARBOR PHARMACEUTICALS, INC.
$171
Xeris Pharmaceuticals, Inc.
$162
PREVENTRIC DIAGNOSTICS, INC.
$156
ABBVIE INC.
$150
Bayer Healthcare Pharmaceuticals Inc.
$149
Kowa Pharmaceuticals America, Inc.
$139
Merck Sharp & Dohme LLC
$100
AbbVie, Inc.
$99
Mylan Specialty L.P.
$84
Abbott Laboratories
$80
Otsuka America Pharmaceutical, Inc.
$73
Shield Therapeutics Inc
$60
Sumitomo Pharma America, Inc.
$59
Biohaven Pharmaceutical Holding Company Ltd.
$59
Valeritas, Inc.
$58
Medtronic, Inc.
$47
Ironwood Pharmaceuticals, Inc
$43
Biohaven Pharmaceuticals, Inc.
$40
Azurity Pharmaceuticals, Inc.
$36
Arbor Pharmaceuticals, Inc.
$35
Medtronic MiniMed, Inc.
$31
SHIELD THERAPEUTICS INC
$31
Akcea Therapeutics, Inc.
$29
Avanir Pharmaceuticals, Inc.
$28
Zyla Life Sciences
$25
Global Blood Therapeutics, Inc.
$24
West-Ward Pharmaceuticals
$24
Medicure Pharma Inc.
$23
Actelion Pharmaceuticals US, Inc.
$23
EISAI INC.
$21
Allergan Inc.
$21
Corium, LLC
$20
Noden Pharma USA Inc
$19
Allergan, Inc.
$17
ARALEZ PHARMACEUTICALS US INC.
$16
Aytu BioScience, Inc
$16
Hikma Pharmaceuticals USA
$12
Top 3 companies account for 74.4% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ANORO · ANORO ELLIPTA · Adlarity · Aimovig · Amitiza · Androgel · BAQSIMI · BASAGLAR · BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · Belviq · Bidil · CHANTIX · CYCLOSET · DIABETES - DISEASE · EMGALITY · ENTRESTO · EUCRISA · Edarbi · Edarbyclor · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GARDASIL 9 · GEMTESA · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · Guardian Connect · HUMIRA · Horizant · INTELLIS ADAPTIVESTIM · InPen · JANUVIA · JARDIANCE · JYNARQUE · Kerendia · Korlym · LEQVIO · LINZESS · LOKELMA · LONHALA MAGNAIR · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Minimed 630G · Mitigare · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · Nuedexta · OPSUMIT · OXBRYTA · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRADAXA · PREMARIN · PROCLAIM · REXULTI · RINVOQ · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Saxenda · Synthroid · TAVNEOS · TEGSEDI · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TRUMENBA · Tresiba · Trintellix · Tuzistra XR · UBRELVY · UTIBRON NEOHALER · Utibron · V-GO · VERQUVO · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · Xultophy 100/3.6 · YUPELRI · ZONTIVITY · ZORVOLEX · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (74%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for family medicine in NC.

Looking for a family medicine specialist in Greensboro?
Compare family medicine physicians in the Greensboro area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
386
Per 100K population
71.1
County median income
$66,027
Nearest hospital
MOSES H. CONE MEMORIAL HOSPITAL, THE
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Bland is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 1% of NC peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Bland experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bland performed 303 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bland receive payments from pharmaceutical companies?
Yes. Dr. Bland received a total of $50,902 from 59 companies across 792 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bland's costs compare to other family medicine physicians in Greensboro?
Dr. Bland's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bland) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →